KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, including ...

DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.

Last year, the regulator also banned the issuance of a certificate that facilitated the trade, according to minutes of an FDA board of directors meeting in July last year. Pyne and Bonwin claim ...

Walbert, former chairman, president and chief executive officer of Horizon Therapeutics, to the company's Board of Directors, effective Feb. 24, 2025. Mr. Walbert led Horizon, a company that ...

The Society for the Conservation of Nature of Liberia (SCNL) at its 39th Anniversary retires its Broad Chair Mr. Alexander L. Peal and Prof. John T. Woods as member of broad. The two happened to be ...

Patrizia Cavazzoni was formerly director of the FDA’s Center for Drug Evaluation ... now serves on the board of Pfizer. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has ...

“We are pleased to welcome Andrew to ReAlta’s Board of Directors,” said David Marek ... approved by the FDA as COBENFY™ for schizophrenia in 2024. During his tenure at Karuna, he played ...

"We are pleased to welcome Andrew to ReAlta’s Board of Directors," said David Marek ... He played a lead role in developing KarXT, approved by the FDA as COBENFY™ for schizophrenia in 2024.

Laurent Leksell, Elekta’s chairman of the board, said the company needs “new leadership that can further intensify the focus on improving profitability and strengthen growth.” ...

A truck with chewing sticks parked near an open field. Some of the sticks lay on the ground. It had been parked for three weeks in Barlome Town on the Grand Bassa-River Cess highway. The sticks had ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...